×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
SOCIAL MEDIA, PATIENTS AND PUBLIC POLICY
Session Chair(s)
Alastair Kent, MHS
Co-Chair of the UK Rare Disease Policy Board; Former Executive Director
Genetic Alliance UK, United Kingdom
Perspectives on Stakeholder Engagement in Regulatory Intelligence Activities
Learning Objective : • Awareness of the importance of stakeholder engagement in regulatory intelligence activities within companies and strategies for improvement • Understanding of how the EMA is re-developing their website to meet the information needs of its business users • Insight into Knowledge Management initiatives that could aid stakeholder engagement activities
Speaker(s)
Using Social Media Tools to Change the Nature of Research
Ifty Ahmed
Pow Health, United Kingdom
CEO
The EPF's View of Social Media
Nicola Bedlington
European Patient's Forum, Belgium
Special Advisor
Perspectives on Stakeholder Engagement in Regulatory Intelligence Activities
Carolyn Louise Hynes, PhD
GlaxoSmithKline, United Kingdom
Senior Director, Global Regulatory Intelligence
Have an account?